News summary
[CITIC Construction Investment: The innovative drug industry continues to upgrade and compete for the global market] Securities Times News, CITIC Construction Investment Research News pointed out that in recent years, with the vigorous development of innovative drugs in China, more and moreJungleJackpotJingleChinese pharmaceutical companies are turning overseas to win moreJungleJackpotJingleDevelopment opportunities and market share, the global marketJungleJackpotJingle.JungleJackpotJingle..
Newsletter text
[CITIC Construction Investment: The innovative drug industry continues to upgrade and compete for the global market] Securities Times News, CITIC Construction Investment Research pointed out that in recent years, with the vigorous development of innovative drugs in China, more and more Chinese pharmaceutical companies have turned their goals overseas. In order to win more development opportunities and market share, the great opportunities in the global market give innovative drugs impetus to go abroad. With the continuous iteration of innovative technologies, the global competitiveness of China's innovative drugs continues to improve. Under the "three-step" model of going to sea, Chinese innovative pharmaceutical companies continue to successfully go out to the world. Overall, China's innovative drug authorizations have entered a harvest period. After 2020, the down payment and total amount of license-out of domestic pharmaceutical companies will increase significantly, and the future is promising. Proofread: Ran Yanqing